The structure and ion channel activity of 6-benzylamino-3-hydroxyhexa-cyclo[6.5.0.0(3,7).0(4,12).0(5,10).0(9,13]tridecane
- PMID: 12761766
- DOI: 10.1002/ardp.200390009
The structure and ion channel activity of 6-benzylamino-3-hydroxyhexa-cyclo[6.5.0.0(3,7).0(4,12).0(5,10).0(9,13]tridecane
Abstract
A novel compound, 6-benzylamino-3-hydroxyhexacyclo [6.5.0.0(3, 7).0(4, 12).0(5, 10).0(9, 13)]-tridecane, was synthesized as part of an ongoing study to explore the ion channel activity of polycyclic cage amines. The known polycyclic calcium channel antagonist, 8-benzylamino-8, 11-oxapentacyclo [5.4.0.0(2, 6).0(3, 10).0(5, 9)]undecane (NGP 1-01) served as the lead compound and as a positive control for channel activity. The title compound inhibited calcium currents at test concentrations of 10 microM at depolarized membrane potentials (in the potential range where the L-type calcium channel inactivates). At the test concentrations modulating effects were also observed for sodium and the delayed rectifier potassium currents. Due to its activity at both Ca(2+) and Na(+) channels, this compound may offer utility as a cardiovascular and/or neuroprotecting agent.
Similar articles
-
Electrophysiological effects of protopine in cardiac myocytes: inhibition of multiple cation channel currents.Br J Pharmacol. 2000 Mar;129(5):893-900. doi: 10.1038/sj.bjp.0703132. Br J Pharmacol. 2000. PMID: 10696087 Free PMC article.
-
Enantiomeric resolution of the calcium channel antagonist 8-benzylamino-8,11-oxapentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]unde cane (NGP 1-01).Pharmazie. 1998 Dec;53(12):859-62. Pharmazie. 1998. PMID: 9879570
-
The effect of the isomers of cyclo(Trp-Pro) on heart and ion-channel activity.J Pharm Pharmacol. 2002 Dec;54(12):1659-65. doi: 10.1211/002235702252. J Pharm Pharmacol. 2002. PMID: 12542896
-
Pharmacology of cardiac potassium channels.Adv Pharmacol. 2010;59:93-134. doi: 10.1016/S1054-3589(10)59004-5. Adv Pharmacol. 2010. PMID: 20933200 Review.
-
Ion channels as drug targets in central nervous system disorders.Curr Med Chem. 2013;20(10):1241-85. doi: 10.2174/0929867311320100005. Curr Med Chem. 2013. PMID: 23409712 Free PMC article. Review.
Cited by
-
Polycyclic compounds: ideal drug scaffolds for the design of multiple mechanism drugs?Neurotherapeutics. 2009 Jan;6(1):175-86. doi: 10.1016/j.nurt.2008.10.037. Neurotherapeutics. 2009. PMID: 19110208 Free PMC article. Review.
-
Calcium Modulating Effect of Polycyclic Cages: A Suitable Therapeutic Approach Against Excitotoxic-induced Neurodegeneration.Mini Rev Med Chem. 2024;24(13):1277-1292. doi: 10.2174/0113895575273868231128104121. Mini Rev Med Chem. 2024. PMID: 38275027 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous